NFKB1 and Alzheimer disease: Based on the results of western blot analysis, the protein level of Sox9 was decreased, followed by the decline of the proteins in the NF-κB complex, confirming that miR-22-3p could ameliorate the AD by targeting Sox9 through the NF-κB signaling pathway in the hippocampus.